BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 11228491)

  • 21. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis.
    Boneu B; Bes G; Pelzer H; Sié P; Boccalon H
    Thromb Haemost; 1991 Jan; 65(1):28-31. PubMed ID: 2024237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.
    Speiser W; Mallek R; Koppensteiner R; Stümpflen A; Kapiotis S; Minar E; Ehringer H; Lechner K
    Thromb Haemost; 1990 Oct; 64(2):196-201. PubMed ID: 2125371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Akamatsu N; Kishi Y; Makuuchi M
    Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
    Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
    Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
    Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
    Levine AB; Teppa J; McGough B; Cowchock FS
    Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Haemocoagulative modifications correlated with pregnancy].
    Borrelli AL; De Lucia D; Bernacchi M; Napolitano M; Di Domenico A; Felicetti M; Ferrara C; Meo D; Raffio R; Rivetti A; Sessa M; Tagliaferri A; Torella M
    Minerva Ginecol; 2006 Aug; 58(4):315-22. PubMed ID: 16957675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of prothrombin fragment 1 + 2 and fibrin dimer in the detection of hypercoagulation in obstetrical patients with thrombosis risk factors].
    Romero-García F; Angulo-Vázquez J; Hernández-Montiel JL; Luna-Zaizar H; de la Torre-Torres S
    Ginecol Obstet Mex; 1998 Nov; 66():456-61. PubMed ID: 9823703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
    Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
    J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
    Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
    J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies.
    Morikawa M; Yamada T; Turuga N; Cho K; Yamada H; Sakuragi N; Minakami H
    J Perinat Med; 2006; 34(5):392-7. PubMed ID: 16965226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.
    Dati F; Pelzer H; Wagner C
    Semin Thromb Hemost; 1998; 24(5):443-8. PubMed ID: 9834011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
    Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
    Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma coagulation markers with prophylactic treatment of low molecular weight heparin after cesarean section.
    Hirota Y; Sakai M; Nakabayashi M
    Semin Thromb Hemost; 2005 Jun; 31(3):253-60. PubMed ID: 16052393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemostatic reference intervals in pregnancy.
    Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.